Impact of diabetes on long‐term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry

It is still unclear the impact of diabetes mellitus (DM) in complex coronary lesions treated with percutaneous coronary intervention (PCI) which themselves are at increased incidence of adverse events.

[1]  G. Helft,et al.  Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions , 2022, JACC. Asia.

[2]  G. Helft,et al.  Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry). , 2021, The American journal of cardiology.

[3]  Hyo‐Soo Kim,et al.  Incidence and Predictors of Stent Thrombosis in Patients Treated with Stents for Coronary Bifurcation Narrowing (From the BIFURCAT Registry). , 2021, The American journal of cardiology.

[4]  F. Burzotta,et al.  Percutaneous Coronary Intervention For Bifurcation Coronary Lesions.The 15th Consensus Document from the European Bifurcation Club. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  F. D’Ascenzo,et al.  Percutaneous vs. surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5 years follow-up RCTs. , 2020, European heart journal. Quality of care & clinical outcomes.

[6]  Seung‐Jung Park,et al.  Long‐Term (10‐Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus , 2020, Journal of the American Heart Association.

[7]  Deepak L. Bhatt,et al.  Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association. , 2020, Circulation.

[8]  F. Burzotta,et al.  Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations , 2020, Circulation. Cardiovascular interventions.

[9]  A. Gnasso,et al.  Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study , 2019, Diabetes & vascular disease research.

[10]  L. Newby,et al.  Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[11]  S. Pocock,et al.  Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes. , 2019, Journal of the American College of Cardiology.

[12]  P. Portincasa,et al.  Update on pathological platelet activation in coronary thrombosis , 2018, Journal of cellular physiology.

[13]  Michael C. McDaniel,et al.  Low Coronary Wall Shear Stress Is Associated With Severe Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease. , 2018, JACC. Cardiovascular interventions.

[14]  E. V. van Beek,et al.  Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction , 2018, The New England journal of medicine.

[15]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[16]  B. Tang,et al.  Should kissing balloon inflation after main vessel stenting be routine in the one-stent approach? A systematic review and meta-analysis of randomized trials , 2018, PloS one.

[17]  J. Spertus,et al.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, European heart journal.

[18]  G. Stone,et al.  Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients , 2017, European heart journal.

[19]  P. Serruys,et al.  Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis , 2017, European heart journal cardiovascular Imaging.

[20]  M. Morice,et al.  Contemporary Approach to Coronary Bifurcation Lesion Treatment. , 2016, JACC. Cardiovascular interventions.

[21]  K. Seung,et al.  Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts. , 2016, JACC. Cardiovascular interventions.

[22]  M. Jeong,et al.  Long-Term Clinical Outcomes of Final Kissing Ballooning in Coronary Bifurcation Lesions Treated With the 1-Stent Technique: Results From the COBIS II Registry (Korean Coronary Bifurcation Stenting Registry). , 2015, JACC. Cardiovascular interventions.

[23]  Marc P. Bonaca,et al.  Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[24]  G. Stone,et al.  Clinical ResearchInterventional CardiologyImpact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus: Analysis From 18 Pooled Randomized Trials , 2014 .

[25]  M. Jeong,et al.  Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II. , 2014, JACC. Cardiovascular interventions.

[26]  Renu Virmani,et al.  Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. , 2010, Journal of the American College of Cardiology.

[27]  Corrigendum to: 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2019, European heart journal.

[28]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[29]  F. Gaita,et al.  Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. , 2013, Atherosclerosis.